Neuren Pharmaceuticals appoints experienced industry executive to board

Latest News

Neuren Pharmaceuticals (ASX:NEU) has announced the appointment of Joe Basile as an independent non-executive director.

Mr Basile has held a number of executive roles in the pharmaceutical industry for over 30 years, most recently as the chief financial officer of iNova Pharmaceuticals based in Singapore and prior to that with Novartis in senior finance leadership and commercial sales leadership roles in Australia and Asia.

Mr Basile has extensive experience in corporate mergers and acquisitions, capital management and overseeing expansion activities across multiple countries with a sharp focus on shareholder value creation.

Neuren Chair Patrick Davies said, “Joe brings a wealth of industry and commercial experience to Neuren and I am delighted he has joined the Board at a time of great opportunity for our company as we pursue our growth plans. I’m sure we will benefit from Joe’s strong financial acumen and his experience with guiding rapidly expanding businesses to achieve their full potential.”